P-52 CHARACTERIZATION OF SERUM METABOLOMIC PROFILE BY NMR IN PATIENTS WITH VARIOUS DEGREES OF HEPATIC ENCEPHALOPATHY.
No Hepatic encephalopathy (HE) is a complication of liver failure whose clinical identification is commonly delayed. Measurement of parameters reflecting HE would be desirable in clinical practice. Metabolomic study using nuclear magnetic resonance (NMR) represents a strategy in this regard, with advantages such as detecting numerous types of metabolites. Objetive: To characterize the serum metabolomic profile (SMP) of various clinical stages of HE severity using NMR. Observational, cross-sectional, analytical, prospective study. Anthropometric, hematologic, and biochemical parameters were evaluated in patients >18 years: 15 controls (C), 18 hepatopathy without HE (HSHE), 11 minimal HE (HEM), 9 West Haven (WH) I, 12 WHII, 9 WHIII, and 8 WHIV. SMP was analyzed by NMR, characterizing the profile per patient, study group, and analyzed by PLS-DA using MetaboAnalyst 5.0 platform. Signals from 45 metabolites were assigned, quantifying 43. PLS-DA showed differences in SMP between groups, with metabolite concentrations decreasing as HE severity increased, except for 3-methylhistidine, which increased with HE severity. Acetone, lysine, glycerol, and serine were higher in C compared to HSHE and HEM; proline, cysteine, threonine, alanine, 3-hydroxybutyrate, and isoleucine were higher in HEM or HSHE compared to WHI and WHII. The metabolite/creatinine index identified 14 metabolites that differentiated the groups (3-methylhistidine, acetone, proline, 3-hydroxybutyrate, lysine, cysteine, threonine, glycerol, glycine, lactate, alanine, serine, valine, and isoleucine). SMP differed among the groups, with metabolites implicated in severe HE including arginine, isoleucine, valine, alanine, histidine, threonine, glycerol, serine, tyrosine, glutamine, phenylalanine, formate, ornithine, tau-methylhistidine, and methionine. Implicated metabolic pathways were phenylalanine, tyrosine, and tryptophan; phenylalanine; histidine; glycine, serine, and threonine; glutathione. WH has an objective and measurable explanation using metabolomics.
Authors
- Linda E. Muñoz‐Espinosa (ORCID: https://orcid.org/0000-0002-0455-9325)
- Edgar Mendoza (ORCID: https://orcid.org/0000-0002-1991-4721)
- Diana Patricia Moreno Peña
- Aina M. Yáñez (ORCID: https://orcid.org/0000-0001-8527-3937)
- Paula Cordero‐Pérez (ORCID: https://orcid.org/0000-0001-7747-8895)
- Roberto Quiroz (ORCID: https://orcid.org/0000-0001-8401-2700)
- Luis Andrés González Torres (ORCID: https://orcid.org/0000-0001-9534-2799)
- Luis Javier González (ORCID: https://orcid.org/0000-0002-8875-3642)
Institutions
- Universidad Autónoma de Nuevo León (MX)
- Universidad Autónoma Metropolitana (MX)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.aohep.2024.101666
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00